Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-06

Clinical Trial Update: A Study of PLH-2301 in Subjects With Sarcopenia [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study of PLH-2301 in sarcopenia in elderly; the trial status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PLH-2301 (PLH-2301)

Snippet

Sponsor: Pluto Inc. | Conditions: Sarcopenia in Elderly | Phase 2 | Status: NOT_YET_RECRUITING